Co-Director Structural Heart Program/ Director Cardiac Catheterization Laboratory
University of Michigan
Ann Arbor , Michigan, United States
Stanley J. Chetcuti, MD is the Director of the Cardiac Catheterization Laboratory, Co-Director of the Multi-Disciplinary Structural Heart Program , at the University of Michigan Hospital and Health Systems a Clinical Professor at the University of Michigan Medical School and The Eric J Topol Collegiate Professor of Cardiology Medicine. He clinical and research practice involves percutaneous aortic valve replacement, percutaneous mitral and tricuspid technologies, and percutaneous circulatory support devices. Dr. Chetcuti’s main research interests are novel therapies in the field of structural heart.
Disclosure(s): Abbott Vascular: Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing); BSCI: Advisor (Ongoing), Clinical Trial Investigator (Ongoing); Edwards Lifesciences LLC: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); MDT: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing)
Saturday, March 9, 2024
12:30 PM – 1:30 PM ET
Saturday, March 9, 2024
12:45 PM – 12:47 PM ET
Panel Discussion & Closing Remarks
Saturday, March 9, 2024
1:16 PM – 1:30 PM ET
LIFETIME MANAGEMENT POST-TAVR AND VALVE IN VALVE
Monday, March 11, 2024
2:33 PM – 4:15 PM ET
Coronary Revascularization Post-TAVR
Monday, March 11, 2024
3:45 PM – 3:53 PM ET
Panel Discussion: Lifetime Management of Patients and Valve-in-Valve with Severe AS
Monday, March 11, 2024
3:53 PM – 4:15 PM ET